192 related articles for article (PubMed ID: 19206408)
1. Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles.
Wu EC; Park JH; Park J; Segal E; Cunin F; Sailor MJ
ACS Nano; 2008 Nov; 2(11):2401-9. PubMed ID: 19206408
[TBL] [Abstract][Full Text] [Related]
2. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging.
Xie M; Shi H; Li Z; Shen H; Ma K; Li B; Shen S; Jin Y
Colloids Surf B Biointerfaces; 2013 Oct; 110():138-47. PubMed ID: 23711784
[TBL] [Abstract][Full Text] [Related]
3. Self-Reporting Photoluminescent Porous Silicon Microparticles for Drug Delivery.
Wang J; Kumeria T; Bezem MT; Wang J; Sailor MJ
ACS Appl Mater Interfaces; 2018 Jan; 10(4):3200-3209. PubMed ID: 29278488
[TBL] [Abstract][Full Text] [Related]
4. Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor.
Lu H; Zhao Q; Wang X; Mao Y; Chen C; Gao Y; Sun C; Wang S
Colloids Surf B Biointerfaces; 2020 Jun; 190():110941. PubMed ID: 32169778
[TBL] [Abstract][Full Text] [Related]
5. Hybrid nanoparticles for drug delivery and bioimaging: mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye.
Xie M; Shi H; Ma K; Shen H; Li B; Shen S; Wang X; Jin Y
J Colloid Interface Sci; 2013 Apr; 395():306-14. PubMed ID: 23394807
[TBL] [Abstract][Full Text] [Related]
6. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
7. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
[TBL] [Abstract][Full Text] [Related]
8. Release and molecular transport of cationic and anionic fluorescent molecules in mesoporous silica spheres.
Ng JB; Kamali-Zare P; Brismar H; Bergström L
Langmuir; 2008 Oct; 24(19):11096-102. PubMed ID: 18767822
[TBL] [Abstract][Full Text] [Related]
9. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
10. Selective functionalization of the internal and the external surfaces of mesoporous silicon by liquid masking.
Wu CC; Sailor MJ
ACS Nano; 2013 Apr; 7(4):3158-67. PubMed ID: 23451853
[TBL] [Abstract][Full Text] [Related]
11. Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin.
Hartmann KI; Nieto A; Wu EC; Freeman WR; Kim JS; Chhablani J; Sailor MJ; Cheng L
J Ocul Pharmacol Ther; 2013 Jun; 29(5):493-500. PubMed ID: 23448595
[TBL] [Abstract][Full Text] [Related]
12. Optimization of analytical assay performance of antibody-gated indicator-releasing mesoporous silica particles.
Costa E; Climent E; Gawlitza K; Wan W; Weller MG; Rurack K
J Mater Chem B; 2020 Jun; 8(22):4950-4961. PubMed ID: 32469027
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-tethered fluorescent silica nanoparticles for pH-responsive anticancer drug delivery.
Zhang P; Kong J
Talanta; 2015 Mar; 134():501-507. PubMed ID: 25618700
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Characterization of Dual-Sensitive Fluorescent Nanogels for Enhancing Drug Delivery and Tracking Intracellular Drug Delivery.
Wu SY; Debele TA; Kao YC; Tsai HC
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534813
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent porous silicon biological probes with high quantum efficiency and stability.
Tu CC; Chou YN; Hung HC; Wu J; Jiang S; Lin LY
Opt Express; 2014 Dec; 22(24):29996-30003. PubMed ID: 25606929
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured silica materials as drug-delivery systems for Doxorubicin: single molecule and cellular studies.
Lebold T; Jung C; Michaelis J; Bräuchle C
Nano Lett; 2009 Aug; 9(8):2877-83. PubMed ID: 19572735
[TBL] [Abstract][Full Text] [Related]
18. Formation of enzymatic/redox-switching nanogates on mesoporous silica nanoparticles for anticancer drug delivery.
Luo W; Xu X; Zhou B; He P; Li Y; Liu C
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():855-861. PubMed ID: 30948123
[TBL] [Abstract][Full Text] [Related]
19. Aqueous and thermal oxidation of porous silicon microparticles: implications on molecular interactions.
Jarvis KL; Barnes TJ; Prestidge CA
Langmuir; 2008 Dec; 24(24):14222-6. PubMed ID: 19053643
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer.
Siminzar P; Omidi Y; Golchin A; Aghanejad A; Barar J
J Drug Target; 2020 Jan; 28(1):92-101. PubMed ID: 31062625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
